Scinovex
article Open AccessTop 1% cited

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

Circulation Research · 1994 · Vol. 74(6) · pp. 1141–1148
Kathy K. GriendlingC A MinieriJeremy D. OllerenshawR. Wayne Alexander

Abstract

The signaling pathways involved in the long-term metabolic effects of angiotensin II (Ang II) in vascular smooth muscle cells are incompletely understood but include the generation of molecules likely to affect oxidase activity. We examined the ability of Ang II to stimulate superoxide anion formation and investigated the identity of the oxidases responsible for its production. Treatment of vascular smooth muscle cells with Ang II for 4 to 6 hours caused a 2.7 +/- 0.4-fold increase in intracellular superoxide anion formation as detected by lucigenin assay. This superoxide appeared to result from activation of both the NADPH and NADH oxidases. NADPH oxidase activity increased from 3.23 +/- 0.61 to 11.80 +/- 1.72 nmol O2-/min per milligram protein after 4 hours of Ang II, whereas NADH oxidase activity increased from 16.76 +/- 2.13 to 45.00 +/- 4.57 nmol O2-/min per milligram protein. The NADPH oxidase activity was stimulated by exogenous phosphatidic and arachidonic acids and was partially inhibited by the specific inhibitor diphenylene iodinium. NADH oxidase activity was increased by arachidonic and linoleic acids, was insensitive to exogenous phosphatidic acid, and was inhibited by high concentrations of quinacrine. Both of these oxidases appear to reside in the plasma membrane, on the basis of migration of the activity after cellular fractionation and their apparent insensitivity to the mitochondrial poison KCN. These observations suggest that Ang II specifically activates enzyme systems that promote superoxide generation and raise the possibility that these pathways function as second messengers for long-term responses, such as hypertrophy or hyperplasia.

Nitric Oxide and Endothelin EffectsEicosanoids and Hypertension PharmacologySuperoxideNADPH oxidaseAngiotensin IIVascular smooth muscleBiochemistryArachidonic acidOxidase testPhosphatidic acidChemistryIntracellular

MeSH terms

AcridinesAngiotensin IIAnimalsCells, CulturedHypertrophyMultienzyme ComplexesMuscle, Smooth, VascularNADH, NADPH OxidoreductasesSuperoxidesNADPH OxidasesRats

Funding

  • National Institutes of Health
Citations
2,741
FWCI
14.91
field-weighted impact
References
0
Percentile
99%
vs. same field & year
Citations per year
Cited by
Mechanisms of Diabetic Complications
Physiological Reviews · 2013 · 2,735 citations
Vascular smooth muscle contraction in hypertension
Cardiovascular Research · 2018 · 658 citations
Cellular Antioxidant Effects of Atorvastatin In Vitro and In Vivo
Arteriosclerosis Thrombosis and Vascular Biology · 2002 · 591 citations
Reactive Oxygen Species in the Vasculature
Hypertension · 2003 · 1,059 citations
Tissue Angiotensin and Pathobiology of Vascular Disease
Hypertension · 2001 · 746 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.